Sectors
Health, BioTech
Headquarters
New York, New York, USA
CEO
James Peyer
Cambrian Biopharma shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 20.43% discount to their to their last round.Cambrian Biopharma shares, as of Apr 21, 2025, are valued at a price per share implying an approximate 20.43% discount to their to their last round. Cambrian Biopharma shares, as of April 21, 2025, are valued at a price per share implying an approximate +17.66% relative to the most recent significant secondary market activity in October 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Cambrian Biopharma's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Cambrian Biopharma.
Register today to view the full report, with more in-depth details and analytics
Series C Valuation
Latest funding round
$2.47B
XXXXX
2021-10-13
XX-XX-XXXX
PM Insights Implied Valuation
$1.97B
2025-04-21
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
-20.43%
2021-10-13 ➞ 2025-04-21
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
XXXXX
Business Partnerships
Targeted Impact
Who Will Benefit?
What Comes Next?
No items found.
.png)
Cambrian Biopharma shares, as of April 21, 2025, are valued at a price per share implying an approximate +17.66% relative to the most recent significant secondary market activity in October 2024, according to PM Insights' market data. PM Insights uses a market-driven derived price methodology to determine Cambrian Biopharma's valuation when recent secondary market transactions are limited or unavailable, as is currently the case for Cambrian Biopharma.
PM Insights tracks detailed primary funding rounds and verifies cap table directly from original filings for Cambrian Biopharma. Cambrian Biopharma raised $100.0M in its Series C on October 13, 2021, with a price per share reflecting a post-money valuation of $2.47B, according to PM Insights' market data.
No items found.
No items found.
Ready to see it in action?
Schedule a demo with one of our experts
